Cite

HARVARD Citation

    de la Espriella, R. et al. (2020). Efficacy and safety of combined neprilysin and RAS inhibition in heart failure: Let's leave the doubts behind. International journal of cardiology. pp. 198-200. [Online]. 
  
Back to record